Subscribe to RSS
DOI: 10.1055/a-1889-6292
Stage 1 Hypertension in Nulliparous Pregnant Patients and Risk of Unplanned Cesarean Delivery
Funding None.

Abstract
Objective The aim of the study is to determine whether stage 1 hypertension is a risk factor for cesarean at ≥390/7 weeks.
Study Design This is a retrospective cohort study of nulliparas delivering at ≥390/7weeks. Exposure was defined as stage 1 hypertension and compared with normotension. The primary outcome was unplanned cesarean. Statistical analysis was performed using SPSS 27.
Results Two hundred and fifty patients had stage 1 hypertension and 250 had normotension. Thirty-eight percent of the patients with stage 1 hypertension required cesarean as did 22% of controls (risk ratio [RR]=1.55, 95% confidence interval [CI]: 1.23–1.96, p <0.001). This remained significant after controlling for confounders in a logistic regression (odds ratio [OR]=1.61, 95% confidence interval [CI]: 1.02–2.55, p <0.040). Upon secondary analysis, these results were statistically significant for gestational age ≥395/7 weeks (adjusted odds ratio [AOR]=1.89, 95% CI: 1.05–3.39, p=0.033) but not from 390/7 to 394/7weeks (AOR=0.68, 95% CI: 0.31–1.50, p=0.34).
Conclusion In nulliparas, stage 1 hypertension is an independent risk factor for unplanned cesarean.
Key Points
-
Stage 1 hypertension correlates with more cesareans.
-
Unplanned cesarean for nonreassuring fetal status correlates with impaired placental function.
-
Stages 1 and 2 hypertension carry similar risks.
Condensation
Stage-1 hypertension, as newly defined in 2017 by the American Heart Association, is associated with an increased rate of unplanned cesarean delivery in term singleton pregnancies.
Note
This study was presented as a poster at the 41st Annual Pregnancy Meeting, Society for Maternal Fetal Medicine, Virtual, January 25–30, 2021.
Publication History
Received: 16 February 2022
Accepted: 18 June 2022
Accepted Manuscript online:
01 July 2022
Article published online:
08 September 2022
© 2022. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA